Merck & Co., Inc. (MRK)
97.34
+0.46
(+0.47%)
USD |
NYSE |
Dec 10, 13:16
Merck Profit Margin (Quarterly): 33.68% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Biogen, Inc. | 19.00% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Cidara Therapeutics, Inc. | -- |
| Moderna, Inc. | -19.68% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 39.63% |
| Return on Assets | 15.96% |
| Return on Invested Capital | 22.23% |
| Gross Profit Margin (Quarterly) | 75.59% |
| Operating Margin (Quarterly) | 43.43% |
| Return on Net Operating Assets | 23.77% |